| MAXCYTE INC DL-,01 |
| USA |
| Gesundheit |
| US57777K1060 / A2AGVE |
| MYE0 (Frankfurt) / MXCT (NASDAQ) |
| FRA:MYE0, ETR:MYE0, MYE0:GR, NASDAQ:MXCT |
| - |
| https://maxcyte.com/ |
|
MaxCyte, Inc. is a life sciences tools company focused on cell engineering for cell and gene therapy development. MaxCyte designs and commercializes non-viral flow electroporation systems, proprietary processing assemblies, and consumables that help ..
>Volltext.. |
| 128.77 Mio. EUR |
| 50.73 Mio. EUR |
| 27.87 Mio. EUR |
| -24.46 Mio. EUR |
| -31.99 Mio. EUR |
| -0.3 EUR |
| 15.49 Mio. EUR |
| 13.5 Mio. EUR |
| -20.63 Mio. EUR |
| 10.68 |
| -10.42% |
| 17.9% |
| - |
| - |
| - |
| - |
| MAXCYTE |
| 10.11.26 |
|
||||
|